Rybelsus

What is Rybelsus approved to treat?

Rybelsus is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes, and to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes who are at high cardiovascular risk [1]. It shares this FDA label with an Ozempic tablet version of oral semaglutide [1].

How is Rybelsus taken?

Rybelsus is taken orally once daily, on an empty stomach when first waking, with no more than 4 ounces of plain water [1]. Patients must wait at least 30 minutes before eating food, drinking other beverages, or taking other oral medications, and the tablet must be swallowed whole, never split, crushed, chewed, or dissolved [1]. It comes in 3 mg, 7 mg, and 14 mg strengths, different from the Ozempic tablet's 1.5 mg, 4 mg, and 9 mg strengths on that same shared label [1].

How does Rybelsus compare to other oral semaglutide options?

Rybelsus is not the only oral semaglutide tablet: Wegovy also comes as a tablet, on a separate label, indicated for chronic weight management rather than diabetes [2]. Both follow the same once-daily, empty-stomach dosing pattern typical of oral semaglutide.